Hikma Pharmaceuticals (HKMPY)
OTC: HKMPY
· Real-Time Price · USD
48.52
-0.24 (-0.49%)
At close: Oct 15, 2025, 3:59 PM
48.73
0.44%
Pre-market: Oct 15, 2025, 11:12 AM EDT
Hikma Pharmaceuticals Revenue
Hikma Pharmaceuticals reported an annual revenue of $3.13B, reflecting a 8.77% growth. For the quarter ending June 30, 2025, Hikma Pharmaceuticals generated $1.66B in revenue.
Revenue (ttm)
3.13B
Revenue Growth
8.77%
Price / Sales Ratio
1.77
Revenue / Employee
329.16K
Employees
9,500
Market Cap
5.35B
Revenue Chart
History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 3.13B | +8.77% |
Dec 31, 2023 | 2.88B | +14.22% |
Dec 31, 2022 | 2.52B | -1.41% |
Dec 31, 2021 | 2.55B | +9.06% |
Dec 31, 2020 | 2.34B | +6.07% |
Dec 31, 2019 | 2.21B | +6.62% |
Dec 31, 2018 | 2.07B | +6.92% |
Dec 31, 2017 | 1.94B | -0.72% |
Dec 31, 2016 | 1.95B | +35.42% |
Dec 31, 2015 | 1.44B | -3.29% |
Dec 31, 2014 | 1.49B | +9.08% |
Dec 31, 2013 | 1.36B | +23.11% |
Dec 31, 2012 | 1.11B | +20.77% |
Dec 31, 2011 | 918.02M | +25.60% |
Dec 31, 2010 | 730.94M | +14.77% |
Dec 31, 2009 | 636.88M | +9.68% |
Dec 31, 2008 | 580.66M | +29.38% |
Dec 31, 2007 | 448.8M | +41.57% |
Dec 31, 2006 | 317.02M | +20.90% |
Dec 31, 2005 | 262.21M | +23.47% |
Dec 31, 2004 | 212.38M | +101.98% |
Dec 31, 2003 | 105.15M | +22.98% |
Dec 31, 2002 | 85.5M | n/a |